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Abstract  
Introduction: So far, there is no evidence available to demonstrate the relationship between five subgroups 
of total cholesterol/high density lipoprotein cholesterol (TC/HDL-C) ratio with premature myocardial 
infarction (MI).  
Objective: We conducted a case control study to probe more features of the relation between TC/HDL-C 
ratio and the five subgroups of the ratio with myocardial infarction under 55 years and above it. 
Method: A hospital based case control study with incident cases was designed. Cases and controls were 
comprised of 523 under 55-year and 699 above 55-year documented newly diagnosed MI cases, respectively. 
Standardized clinical and para clinical method were used to ascertain disease and risk factors. Independent 
sample t-test, Pearson chi square test, Odds ratios and Mantel-Haenszel test and logistic regression analysis 
conducted to evaluate relationships. 
Results: This study enrolled 1222 MI cases.  Patients with very low risk category of TC/HDL-C ratio estimated 
OR=0.18 with 95% confidence interval (CI) (0.04-0.72) for developing MI under 55 years. Patients who had 
low risk category of TC/HDL-C ratio having OR=0.26 95% CI (0.07-0.89). Low risk and very low risk 
categories of the TC/HDL-C ratio compare to high risk subgroup of the ratio demonstrate decreased risk of 
developing MI under 55 years p<0.05. 
Conclusion: Our study results can be translated as an aggressive treatment for lowering TC/HDL-C ratio in 
both general population and victims of coronary events. Mitigation of the level of TC/HDL-C ratio from low 
risk to very low risk category will attenuate the risk of MI under55 years about 8% which is the immediate 
clinical implication of our findings. 
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INTRODUCTION
The ratio of total cholesterol/ high density 
lipoprotein cholesterol (TC/HDL-C) proved to be a 
strong predictor of future cardiovascular events (1, 
2). It has been shown that the combination of the 
TC/HDL-C ratio associated with elevated high 
sensitive C-reactive protein (Hs-CRP) encompass 
higher predictive value for future cardiovascular 
events (3). Conventional and novel risk factors 
pattern of coronary artery disease (CAD) revealed 
a significant differences among younger 
individuals and the older patients, men and 
women, symptomatic and asymptomatic 
individuals and pre and post- menopausal status in 
women (4-8). 
Variation in the TC/HDL-C ratio across different 
age groups has been found to be augmentative in 
both men and women (9). Investigation of the 
relationship between subgroups of TC/HDL-C ratio 
with premature cardiovascular events might be 
associated with illumination of the alterations exist 
in predictive metabolic indices for incidence of 
ischemic heart events. The ratio of TC/HDL-C may 
be a cumulative index of atherogenic 
dyslipoproteinemia (10).  Elevation of the TC/HDL-
C ratio beyond the level of average risk might be 
associated with attenuated risk for coronary 
events.  
HDL-C level has been recognized as a protective 
lipid factor for occurrence of cardiovascular events 
in different populations (11). Yet measurement of 
this cardio protective lipid component associated 
with traditional lipid profiles has been 
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recommended by abundant recent evidences (1, 2, 
5, 7). In order to tailor a global risk assessment 
model for secondary and primary prevention of 
CAD to dedicate precise preventive measures for 
both healthy individuals and patients with 
cardiovascular presentations we need to address 
the role of various CAD risk factors in a multiple 
risk factor combination. Such a multiple risk factor 
model treats the complexity of the relationship 
between risk factors or preventive factors with 
cardiovascular events. So, control measures which 
designed based on a global risk assessment method 
can guide more efficient and inclusive treatment 
strategies.  
So far, there is no evidence available to 
demonstrate the relationship between five 
subgroups of TC/HDL-C ratio with premature 
coronary events. Therefore, we conducted a case 
control study to figure out more features of the 
relation between five subgroups of TC/HDL-C ratio 
with myocardial infarction under 55 years. 
METHODS 
Study design 
This hospital-based case control study with 
incident cases was designed with adhering to 
STROBE criteria for observational studies. Study 
protocol was approved by the University review 
board (Ethics code: 20219-30-04). Verbal consent 
was obtained at the entry of the study. 
Study population 
Cases: were comprised of 523 documented first 
ever myocardial infarction (MI) patients who were 
under 55 years and randomly selected among MI 
cases admitted to teaching hospitals of the capital 
city.  
Controls: Including 699 documented newly 
diagnosed cases of MI who were above 55 years 
and selected with simple random sampling among 
eligible controls. 
Cases and controls have been matched on diastolic 
hypertension and body mass index. 
Definition 
In order to compare cases and controls based on 
different subgroups of the TC/HDL-C ratio, we 
divided   TC/HDL-C ratio into 5 subgroups refer to 
the national cholesterol education program (NCEP) 
definition (12, 13). These 5 categories including: 
very low risk, low risk, average risk, moderate risk 
and high risk. 
Risk factor detection 
CAD risk factors of cases and controls were 
measured by taking medical history, physical 
examination, laboratory test including: fasting 
plasma sugar enzymatic ally, 12 hours over night 
fasting lipid profile using calorimetric method, and 
calculation of lipid ratios. 
Statistical analysis 
Independent sample t-test, Pearson chi square test, 
Odds ratios calculation and Mantel-Haenszel test 
were done to evaluate univariate and bivariate 
relationships between lipid ratios and premature 
MI. Logistic regression analysis conducted to 
evaluate multivariate adjusted relations between 
first premature MI attack and five categories of 
TC/HDL-C ratios. Analyses were done by predictive 
analytics software and solutions (PAS version 22).  
All statistical comparisons were assumed to be 
significant at P<0.05.    
RESULTS 
This study enrolled 1222 MI cases of both women 
and men. Table 1 shows baseline quantitative 
characteristics among cases and controls. 
Table 2 demonstrates categorical CAD risk factors 
among two study groups.  
Table 3 shows the comparison of two study groups 
across TC/HDL-C ratio categories.  
Cases and controls demonstrate a statistically 
significant differences across five subgroups of the 
Table 1: Comparison of quantitative factors among cases and controls 
p 
Controls Cases 
Variables 
Mean ± SD 
0.001 67.72±7.72 45.84±5.96 Age 
0.007 12.69±2.90 12.30±2.31 Systolic hypertension 
0.92 7.88±1.36 7.82±1.47 Diastolic hypertension 
0.025 145.32±73.14 136.22±67.62 Fasting blood sugar 
0.001 199.47±58.50 210.22±50.76 Cholesterol 
0.001 146.25±79.27 184.94±100.20 Triglyceride 
0.32 42.13±13.28 41.35±14.08 HDL- Cholesterol 
0.002 125.90±39.43 133.46±43.72 LDL- Cholesterol 
0.001 5.06±1.81 5.52±1.92 Cholesterol /HDL-C 
0.001 3.84±2.53 5.05±3.29 Triglyceride/HDL-C 
0.001 3.24±1.35 3.53±1.54 LDL-C/HDL-C 
SD: Standard deviation; HDL-C: High density lipoprotein cholesterol; LDL-C: Low density lipoprotein cholesterol 
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TC/HDL-C ratio (p=0.001).  
Mantel-Haenszel relationship between MI under 
55 years and different subgroups of the TC/HDL-C 
ratio revealed a very interesting results. MI under 
age of 55 years is significantly related to five 
categories of the TC/HDL-C ratio among 
nonsmokers (p=0.01), family history of premature 
CAD (p=0.01), fasting blood sugar>126mg/dl 
(p=0.005), cholesterol<200mg/dl (p=0.006), 
triglyceride<200mg/dl (p=0.006), HDL-
C≤45mg/dl (p=0.006), and LDL-C<130mg/dl 
(p=0.008). 
Multivariable adjusted relations were evaluated in 
a logistic regression model. Parameter estimation 
in regression analysis were made based on 
adjustment for sex, hypertension, body mass index, 
family history of premature CAD, smoking habit 
and LDL-C concentration. After adjustment for 
potential confounding factor outputs of regression 
analysis show that TC/HDL-C ratio is significantly 
related with the occurrence of MI under 55years 
(p=0.004). 
Besides, patients who are in the categories of very 
low risk (p=0.016) and low risk (p=0.032) compare 
to patients having high risk categories according to 
the subgroups of TC/HDL-C ratio show attenuated 
risk for developing MI.  
Patients with very low risk category of TC/HDL-C 
ratio estimated OR=0.18 with 95% confidence 
interval (CI) (0.04-0.72) for developing MI under 
55 years compared to high risk category of 
TC/HDL-C ratio. 
Moreover, CAD patients having low risk category of 
TC/HDL-C ratio in comparison with high risk 
category of the ratio had OR=0.26 95% CI (0.07-
0.89).  
Therefore, very low risk category of the TC/HDL-C 
ratio which present the amount of 3.3-3.4 of this 
ratio accompanied with low risk subgroups which 
comprises of 3.8-4 of the TC/HDL-C ratio compare 
to high risk category of the ratio attenuate the risk 
of developing MI under 55 years p<0.05.  
Table 2: Distribution of categorical factors between cases and controls 
p 
Controls Cases 
Variables 
Number (%) 
0.001 
  Gender       
212 (30.4) 68 (13.0) Female 
485 (69.6) 455 (87.0) Male 
0.001 
  Smoking             
233 (33.4) 301 (57.6) Yes 
464 (66.6) 222 (42.4) No 
0.001 
  Family history of premature CAD  
78 (11.2) 116 (22.3) Yes 
618 (88.8) 404 (77.7) No 
0.027 
  Fasting blood sugar (mg/dl) 
339 (54.8) 309 (61.2) > 126  
313 (45.2) 196 (38.8) ≤ 126 
- 
  Cholesterol (mg/dl) 
0 (0.0%) 0 (0.0) > 200 Mg/dl 
699 (100) 522 (100) ≤ 200Mg/dl 
- 
  Triglyceride (mg/dl) 
0 (0.0) 0 (0.0) > 200 Mg/dl 
699 (100) 523 (100) ≤ 200Mg/dl 
0.22 
  HDL-cholesterol (mg/dl) 
463 (66.2) 363 (69.5) > 45 Mg/dl 
236 (33.8) 159 (30.5) ≤ 45Mg/dl 
0.008 
  LDL-cholesterol (mg/dl) 
400 (57.2) 257 (49.5) > 130Mg/dl 
299 (42.8) 262 (50.5) ≤ 130Mg/dl 
CAD: Coronary artery disease; HDL-C: High density lipoprotein cholesterol; LDL-C: Low density lipoprotein cholesterol 
 
Table 3: Comparison of five categories of total cholesterol/High density lipoprotein cholesterol ratio among cases and controls 
Controls Cases 
Categories 
Number (%) 
27 (3.8) 4 (0.7) Very low risk 
62 (9.0) 15 (2.8) Low risk 
264 (37.8) 161 (30.8) Average risk 
314 (44.9) 307 (58.7) Moderate risk 
31 (4.5) 36 (7.0) High risk 
698 (100) 523 (100) Total 
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DISCUSSION 
The ratio of TC/HDL-C has been recognized as one 
of the most feasible and strong predictor of 
developing future cardiovascular events (1, 2, 5, 6). 
This study provides evidence about the role of 
lower concentration of TC/HDL-C ratio in 
attenuation of the risk of MI under55 years. 
Therefore, aggressive treatment strategies for 
lowering TC/HDL-C ratio could be immediate 
clinical implication of our findings. 
Our study results can be translated as preventive 
measures including: mitigation of cholesterol 
concentration and rising of HDL-C concentration as 
much as possible in general population and also 
among victims of coronary events. Because we 
found that mitigation of the level of TC/HDL-C ratio 
from low risk to very low risk category will 
attenuate the risk of MI under55 years about 8%.  
In the epidemic situation of CAD in our population 
we observed that rate of MI attack under 55 years 
has been raised. Previous evidence of our 
population reported a high level of TC/HDL-C ratio 
including 4.70 and 4.72 for individual with age 
under55 and above 55 years, respectively (4). So 
we need to plan effective and more practical 
preventive strategies to dedicate interventions at 
national level which might be efficacious and 
inclusive. Such a preventive measure must be 
based on research findings associated with 
previous valid and reliable guidelines.  
Our multivariable adjusted findings show patients 
possessing lower level of TC/HDL-C ratio mitigate 
their risk of developing MI attacks. Results of the 
previously published evidence demonstrate that 
trend of increment in TC/HDL-C ratio above age of 
60 years contain a significant augmentative pattern 
and such patients more enjoy attenuation of the 
TC/HDL-C level (5). Mitigation of the atherogenic 
ratio of TC/HDL-C has encompassed beneficial 
effect in both primary, and secondary prevention 
(10, 14). Measurement and properly interpretation 
of the TC/HDL-C ratio amounts is demanded in 
medical practice, especially when abdominal 
obesity and insulin resistance exist (6).  
It has been proven that HDL-C is a cardio protective 
lipid and its low concentration must be a target for 
management (7). The importance of the HDL-c role 
in preventive cardiovascular medicine is even 
higher in primary prevention setting (2, 11, 15, 16).  
Recent genetic researches endorsed the role of 
HDL-C in prediction of future vascular events (17, 
18). Individuals with premature CAD events 
demonstrate lower level of HDL-C (14). In 
secondary prevention trials augmentation of HDL-
C concentration were found to be associated with 
lower mortality rate (19). Our finding shows that 
apart from the ratio of TC/HDL-C, CAD risk factors 
including: high concentration of cholesterol, 
triglyceride, LDL-C, TG/HDL-C and LDL-C/HDL-C 
associated with possessing family history of 
premature CAD, smoking and male gender were 
more common in patients with premature MI. 
however fasting blood sugar and systolic blood 
pressure were found to be lower in this cases. In 
comparison with a large cohort of healthy 
individuals we observed a high concentration of 
cholesterol, triglyceride, LDL-C, and blood sugar 
accompanied with higher rate of smoking, systolic 
and diastolic hypertension, and the ratio of 
TG/HDL-C among healthy people with age above 
55 years (4). Beneficial effect of the attenuation of 
TC/HDL-C ratio in the primary prevention setting 
especially in age under 50 years considered to be 
beyond expectations. Unfortunately, primary 
preventive services for cardiovascular disease are 
suboptimal (20). We recommend measurement of 
TC/HDL-C ratio should be a part of every 
cardiovascular health check in both women and 
men. Especially in women with normal angiogram 
who demonstrate the symptom and signs of cardiac 
ischemia (21). Because in premature CAD 
dyslipoproteinemia is one of the most important 
risk factor for developing future cardiovascular 
events, we should perform more rigorous 
guidelines including measurement and 
management of atherogenic lipid concentrations 
and lipid ratios in our population.  
Our study has numerous strengths that make the 
results of a case control design valid and accurate. 
We matched the cases and controls on body mass 
index and diastolic hypertension in the design 
phase of the study, controlled the role of potential 
confounders in bivariate analysis and finally 
adjusted the role of remaining confounders in a 
multivariable adjusted regression analysis. We 
recruited incident cases to the study to mitigate the 
impact of time and duration of the disease on the 
pre specified relations. CAD risk factor assessments 
were based on standardized protocol for 
measurements concurrently in both study 
populations. MI detection were based on clinical 
presentation, enzymatic findings, 
electrocardiographic, echocardiography, and 
angiographic ally confirmed findings. 
Limitation 
Limitation of our study should be considered as the 
limitations of observational case control designs. 
We will prefer to measure the novel CAD risk 
factors to develop a more precise risk stratification 
models. 
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CONCLUSIONS 
Our study results can be translated as preventive 
measures including: mitigation of cholesterol 
concentration and rising of HDL-C concentration as 
much as possible in general population and also 
among victims of coronary events. We found that 
mitigation of the level of TC/HDL-C ratio from low 
risk to very low risk category will attenuate the risk 
of MI under55 years about 8%. Therefore, 
aggressive treatment strategies for lowering 
TC/HDL-C ratio could be immediate clinical 
implication of our findings. 
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